203 related articles for article (PubMed ID: 34759910)
1. Comparison of CRISPR-Cas Immune Systems in Healthcare-Related Pathogens.
Mortensen K; Lam TJ; Ye Y
Front Microbiol; 2021; 12():758782. PubMed ID: 34759910
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections.
Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G
Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004
[TBL] [Abstract][Full Text] [Related]
3. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
Saha U; Gondi R; Patil A; Saroj SD
Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
[TBL] [Abstract][Full Text] [Related]
4. The CRISPR/Cas system as an antimicrobial resistance strategy in aquatic ecosystems.
Gupta SS; Hamza Kh M; Sones CL; Zhang X; Sivaraman GK
Funct Integr Genomics; 2024 May; 24(3):110. PubMed ID: 38806846
[TBL] [Abstract][Full Text] [Related]
5. Diversity and dynamics of the CRISPR-Cas systems associated with Bacteroides fragilis in human population.
Lam TJ; Mortensen K; Ye Y
BMC Genomics; 2022 Aug; 23(1):573. PubMed ID: 35953824
[TBL] [Abstract][Full Text] [Related]
6. Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens.
Das S; Bombaywala S; Srivastava S; Kapley A; Dhodapkar R; Dafale NA
Environ Sci Pollut Res Int; 2022 Jun; 29(27):40507-40519. PubMed ID: 35349073
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.
González de Aledo M; González-Bardanca M; Blasco L; Pacios O; Bleriot I; Fernández-García L; Fernández-Quejo M; López M; Bou G; Tomás M
Antibiotics (Basel); 2021 Jun; 10(7):. PubMed ID: 34206474
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
mSystems; 2018; 3(3):. PubMed ID: 29719870
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
Pandey R; Mishra SK; Shrestha A
Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
[TBL] [Abstract][Full Text] [Related]
10. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
[TBL] [Abstract][Full Text] [Related]
11. Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa.
van Belkum A; Soriaga LB; LaFave MC; Akella S; Veyrieras JB; Barbu EM; Shortridge D; Blanc B; Hannum G; Zambardi G; Miller K; Enright MC; Mugnier N; Brami D; Schicklin S; Felderman M; Schwartz AS; Richardson TH; Peterson TC; Hubby B; Cady KC
mBio; 2015 Nov; 6(6):e01796-15. PubMed ID: 26604259
[TBL] [Abstract][Full Text] [Related]
12. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pourmohammad A; Saeidvafa S
Infect Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38284691
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of CRISPR-Cas Systems and Their Possible Association with Antibiotic Resistance in
Alduhaidhawi AHM; AlHuchaimi SN; Al-Mayah TA; Al-Ouqaili MTS; Alkafaas SS; Muthupandian S; Saki M
Infect Drug Resist; 2022; 15():1143-1154. PubMed ID: 35340673
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens.
Pursey E; Dimitriu T; Paganelli FL; Westra ER; van Houte S
Philos Trans R Soc Lond B Biol Sci; 2022 Jan; 377(1842):20200464. PubMed ID: 34839714
[TBL] [Abstract][Full Text] [Related]
16. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
[TBL] [Abstract][Full Text] [Related]
17. A bioinformatic approach to identify confirmed and probable CRISPR-Cas systems in the
Mancilla-Rojano J; Flores V; Cevallos MA; Ochoa SA; Parra-Flores J; Arellano-Galindo J; Xicohtencatl-Cortes J; Cruz-Córdova A
Front Microbiol; 2024; 15():1335997. PubMed ID: 38655087
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis.
Price VJ; Huo W; Sharifi A; Palmer KL
mSphere; 2016; 1(3):. PubMed ID: 27303749
[TBL] [Abstract][Full Text] [Related]
19. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.
Ma YX; Wang CY; Li YY; Li J; Wan QQ; Chen JH; Tay FR; Niu LN
Adv Sci (Weinh); 2020 Jan; 7(1):1901872. PubMed ID: 31921562
[TBL] [Abstract][Full Text] [Related]
20. Rosin as a Natural Alternative for the effective disinfection of ESKAPE Pathogens and Clostridioides difficile spores.
Bell S; Thompson TP; Marks N; Fairley D; Kettunen H; Vuorenmaa J; Orte J; Gilmore BF; McGrath JW
J Appl Microbiol; 2024 Jan; ():. PubMed ID: 38244225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
